Dermatitis: all 1,425 studies

Page 7 of 15. Open to participants first (127), then studies with results posted, then the rest; newest registration first within each.

• An Exploratory Investigation of a Novel Skincare RegimenCompletedNCT05517720Not applicable
• Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)Active, not recruitingNCT05509023Phase 2
• Topical Steroids & Bacterial Decolonization for Radiation DermatitisWithdrawnNCT05505214Phase 2
• Targeting Staphylococci in Atopic DermatitisStatus unknownNCT05502185
• Crossover Study to Evaluate the Efficacy of LED in Treating the Signs of Contact/Irritant Dermatitis of the HandCompletedNCT05497921Not applicable
• A Clinical Trial of BMX-010 in Adult Subjects With Atopic DermatitisTerminatedNCT05491447Phase 2
• Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic DermatitisCompletedNCT05487963Phase 1/2
• Adjuvant Effect of Photobiomodulation in the Treatment of Incontinence-associated Dermatitis in AdultsWithdrawnNCT05471180Not applicable
• Clinical Relevance of Scratching and Sleep in Atopic DermatitisCompletedNCT05467046
• A Study of MG-K10 in Subjects With Atopic DermatitisActive, not recruitingNCT05466877Phase 2
• Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%CompletedNCT05461456Phase 1
• StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation DermatitisCompletedNCT05450848Not applicable
• A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in TaiwanCompletedNCT05442645
• Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic DermatitisStatus unknownNCT05437887Not applicable
• Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisCompletedNCT05432596Phase 2
• Effect of Using Oxygen on the Diaper Dermatitis in InfantsCompletedNCT05427760Not applicable
• ECP for Immune-related Adverse Events After Checkpoint Inhibitor TreatmentCompletedNCT05414552
• A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult SubjectsStatus unknownNCT05409326Phase 1
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic DermatitisTerminatedNCT05387707Phase 3
• A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic DermatitisCompletedNCT05383378Phase 1
• A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic DermatitisTerminatedNCT05382819Phase 1
• IL-4 and Insulin Resistance for Treatment of Patients With Atopic DermatitisCompletedNCT05372003Early Phase 1
• Allergy Skin Patch Artificial Intelligence (AI)CompletedNCT05339750Not applicable
• Study to Evaluate the Safety of ColchicineActive, not recruitingNCT05335148Phase 1
• Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic DermatitisStatus unknownNCT05326672Phase 3
• Tacrolimus Versus Hydrocortisone in Atopic DermatitisCompletedNCT05324618Phase 4
• Evaluation of an Adapted Formula on Atopic Dermatitis.Active, not recruitingNCT05318300Not applicable
• Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced ErythemaCompletedNCT05300542Not applicable
• Clinical Trial to Evaluate Safety and Efficacy of Jalosome® Soothing Gel.Status unknownNCT05284487Not applicable
• The Effect of Wearing Facial Masks on Skin Parameters During the COVID-19 PandemicStatus unknownNCT05277324
• Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children StudyCompletedNCT05276323Phase 2
• The Effects of Repeated Exposure to Antiseptics During COVID-19 Pandemic on Skin ParametersStatus unknownNCT05276102Not applicable
• Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years?WithdrawnNCT05275257Not applicable
• A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05265923Phase 3
• Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.Status unknownNCT05265234Phase 4
• Implementation of a Minor Ailment Service in Community Pharmacy PracticeCompletedNCT05247333Not applicable
• A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)CompletedNCT05235724
• HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
• Immunomodulation by OM-85 (Broncho-Vaxom) in Early ADTerminatedNCT05222516Phase 2
• A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf CountriesCompletedNCT05214326
• Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT05203380
• The Study of CM326 in Patients With Moderate-to-severe Atopic DermatitisStatus unknownNCT05186922Phase 1/2
• Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic DiseaseCompletedNCT05177744
• A Clinical Study in Healthy Subjects to Evaluate 9MW1911 InjectionCompletedNCT05170243Phase 1
• Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic DermatitisCompletedNCT05158023Phase 2
• Scratching Validation StudyCompletedNCT05137093
• Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic DermatitisStatus unknownNCT05136261Phase 3
• Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.CompletedNCT05125458
• A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin InjuryStatus unknownNCT05114226Phase 1
• Effects of Tildrakizumab on Epigenetic AgeCompletedNCT05110313Phase 4
• Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of ScalpCompletedNCT05105139
• Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory ComplicationsCompletedNCT05104723Phase 1/2
• The Effect of Avocado vs. Usual Diet on Skin AgingCompletedNCT05102604Not applicable
• A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese SubjectsCompletedNCT05099133Phase 1
• The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicCompletedNCT05098600
• A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin ParticipantsCompletedNCT05094700Not applicable
• Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic DermatitisStatus unknownNCT05092464Not applicable
• Creation of a Shared Medical Decision-making Tool for Atopic DermatitisStatus unknownNCT05090982
• The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh PopulationCompletedNCT05090631
• Results in Real Clinical Practice of Treatment of Moderate-severe Atopic DermatitisStatus unknownNCT05078294
• StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer PatientsWithdrawnNCT05073172Not applicable
• Electrochemistry Measurement of Skin Hydration ParametersStatus unknownNCT05071456Not applicable
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.CompletedNCT05062213Not applicable
• Evaluate Efficacy of FB825 in Adults With Atopic DermatitisCompletedNCT05059509Phase 2
• A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic DermatitisCompletedNCT05057351Not applicable
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically AdvisableWithdrawnNCT05056779Phase 3
• Study of Ruxolitinib Cream in Children With Atopic DermatitisCompletedNCT05034822Phase 1
• Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal EvaluationStatus unknownNCT05031754
• China Atopic Dermatitis Registry StudyStatus unknownNCT05023668
• Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis PatientsCompletedNCT05019209Not applicable
• Comparison of JW-100 and EUCRISA for the Treatment of Atopic DermatitisWithdrawnNCT05016284Phase 3
• Evaluation of the Efficacy of Topialyse Baume barrière on Atopic DermatisWithdrawnNCT05006300Not applicable
• Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)Status unknownNCT05004324Phase 3
• Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Radiation Care® GelCompletedNCT04995328Not applicable
• Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic PatientsCompletedNCT04984941
• Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic DermatitisCompletedNCT04976868
• Ocular Comorbidity in Atopic DermatitisActive, not recruitingNCT04973384
• Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant PhenotypesWithdrawnNCT04965233
• Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic DermatitisTerminatedNCT04955951
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.WithdrawnNCT04950374Not applicable
• Study on the Correlation Between Intestinal Microecology and Allergic Diseases in ChildrenStatus unknownNCT04938700Phase 4
• The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin DiseasesStatus unknownNCT04937101Not applicable
• Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 StudyTerminatedNCT04936113Phase 2
• Novel Skin Care Product for the Management of Acute RadiodermatitisCompletedNCT04929808Not applicable
• Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic DermatitisCompletedNCT04927572Phase 1/2
• Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild AsthmaCompletedNCT04927195Phase 1
• Children With Aluminium Contact Allergy: Oral Exposure StudyCompletedNCT04921163Not applicable
• An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevicesTerminatedNCT04909983Not applicable
• Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of LifeCompletedNCT04900948Phase 4
• Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in ChildhoodStatus unknownNCT04895423Phase 4
• Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04893941Phase 1/2
• The Study of CM310 in Patients With Atopic DermatitisCompletedNCT04893707Phase 2
• Tahini and Dermatitis in Breast CancerStatus unknownNCT04890197Not applicable
• Grape Juice and Dermatitis in Breast CancerStatus unknownNCT04890184Not applicable
• Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.Status unknownNCT04888234Phase 2
• NMF-CsA-Dupi TrialStatus unknownNCT04878770Not applicable
• Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT04875169Phase 3
• A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APBStatus unknownNCT04853823Phase 1
• Dilute Bleach Compresses for Radiation DermatitisWithdrawnNCT04851522Early Phase 1
• Pleiotropic Role of TRPV1 in Psoriasis InflammationCompletedNCT04848194Not applicable

← Dermatitis overview